ProCE Banner Activity

NF1: Current State of Disease Understanding

Slideset

Download these slides on neurofibromatosis type 1 (NF1) including the underlying cause, diagnostic criteria, and tumor predisposition syndrome.

Released: November 21, 2024

Expiration: November 20, 2025

Share

Faculty

Jaishri Blakeley

Jaishri Blakeley, MD

The Marjorie Bloomberg Tiven Professor of Neurofibromatosis
Director, The Neurofibromatosis Therapeutic Acceleration Program
Director, the Johns Hopkins Comprehensive Neurofibromatosis Program
Professor of Neurology, Neurosurgery and Oncology
The Johns Hopkins School of Medicine
Baltimore, Maryland

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from Alexion Pharmaceuticals and SpringWorks Therapeutics, Inc.

Alexion Pharmaceuticals

SpringWorks Therapeutics, Inc.